[Frontiers in Bioscience S2, 117-134, January 1, 2010]

Molecular and functional genetics of hepatocellular carcinoma

Judy Wai Ping Yam, Chun Ming Wong, Irene Oi-Lin Ng

Liver Cancer and Hepatitis Research Laboratory, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. Molecular pathogenesis of hepatocellular carcinoma
3.1. Multistep hepatocarcinogenesis
4. Genetic alterations in hepatocarcinogenesis
4.1. Chromosomal abnormalities
4.2. Somatic mutational analysis
4.3. Single nucleotide polymorphism
5. Epigenetic modifications in hepatocarcinogenesis
6. Mouse model of hepatocellular carcinoma
6.1. Mdr2 knockout mouse model
6.2. Transgenic mice of hepatitis virus
7. Signaling pathways in hepatocellular carcinoma
7.1. Wnt/b-catenin pathway
7.2. Ras signaling pathway
7.3. PI3K/Akt/mTOR
8. Perspective
9. Acknowledgements
10. References

1. ABSTRACT

Hepatocellular carcinoma (HCC) is the fifth most common cancer and one of the leading causes of cancer death worldwide. Hepatocarcinogenesis is a multistep process developing from normal through chronic hepatitis/cirrhosis and dysplastic nodules to HCC. Although we have insufficient understanding to propose a robust general model, with advances in molecular methods, there is a growing understanding of the molecular mechanisms in the development of HCC. Hepatocarcinogenesis is strongly linked to increases in allelic losses, chromosomal changes, gene mutations, epigenetic alterations, and alterations in molecular cellular pathways. Special emphasis in this review is given to the genetics, epigenetics, and regulation of major signaling pathways involved in HCC such as Wnt/b-catenin, Ras, and PI3K/Akt/mTOR pathways. A detailed understanding of the underlying molecular mechanisms involved in the progression of HCC can improve our prevention and diagnostic tools for HCC and be an important potential source of novel molecular targets for new therapies.